Regarding GCS expression in the group of glioblastoma patients, only a small group of 10 patients showed a more than 2-fold GCS upregulation, associated with a significant decrease in probability of survival, whereas only one patient was found in the Rembrandt database showing a more than 2-fold reduced GCS mRNA expression. This evidence concerns the gene UGCG and glioblastoma.